Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others > Other Targets

Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC77996 Vasoactive intestinal peptide
Vasoactive intestinal peptide is an agonist of VPAC1/VPAC2 receptor (G-protein-coupled receptors). Vasoactive intestinal peptide reduces corneal perforation rate, bacterial load, and excessive neutrophil infiltration in Pseudomonas aeruginosa-induced keratitis models. Vasoactive intestinal peptide enhances anti-inflammatory mediators like IL-10 and TGF-β, inhibites pro-inflammatory factors such as IL-1β and TNF-α, and upregulates lipid mediator-related enzymes (SOCS3, COX-2, ALOX12) to promote inflammation resolution. Vasoactive intestinal peptide is promising for research of ocular infectious diseases.
More description
DC77989 Superoxide dismutase PEG
Superoxide dismutase PEG (EC 1.15.1.1) is a mimetic of superoxide dismutase (SOD) and powerful free radical scavenger acts by reducing superoxide anions.
More description
DC77987 Solbinsiran
Solbinsiran is a siRNA targeted to hepatic ANGPTL3.
More description
DC77986 Solbinsiran sodium
Solbinsiran sodium is a siRNA targeted to hepatic ANGPTL3.
More description
DC77983 Senvesiran
Senvesiran, a siRNA, is a ketohexokinase synthesis reducer.
More description
DC77982 Senvesiran sodium
Senvesiran sodium, a siRNA, is a ketohexokinase synthesis reducer.
More description
DC77979 scrambled IONIS-MAPTRx sodium
Scrambled IONIS-MAPTRx (sodium) is a scrambled sequence of IONIS-MAPTRx sodium. Scrambled IONIS-MAPTRx (sodium) has the same amino acid composition as the active IONIS-MAPTRx sodium fragment, but the sequence is randomly scrambled. Scrambled IONIS-MAPTRx (sodium) is typically used as a negative control. Scrambled IONIS-MAPTRx (sodium) has potential for studying Alzheimer's disease.
More description
DC77977 Sapablursen
Sapablursen, an antisense oligonucleotide, is designed to reduce the production of TMPRSS6 resulting in increased expression of hepcidin, which is the key regulator of iron homeostasis. Sapablursen can be used in the research of blood diseases such as pol
More description
DC77976 Sapablursen sodium
Sapablursen sodium, an antisense oligonucleotide, is designed to reduce the production of TMPRSS6 resulting in increased expression of hepcidin, which is the key regulator of iron homeostasis. Sapablursen sodium can be used in the research of blood diseas
More description
DC77974 Rimigorsen
Rimigorsen is an antisense oligonucleotide that induces skipping of exon 44 of the pre-mRNA encoding dystrophin in a Duchenne muscular dystrophy (DMD)
More description
DC77973 Rimigorsen sodium
Rimigorsen sodium is an antisense oligonucleotide that induces skipping of exon 44 of the pre-mRNA encoding dystrophin in a Duchenne muscular dystrophy (DMD)
More description
DC77972 Renadirsen
Renadirsen is an antisense oligonucleotide that induces robust Exon 45 skipping for Dystrophin in vivo.
More description
DC77971 Renadirsen sodium
Renadirsen sodium is an antisense oligonucleotide that induces robust Exon 45 skipping for Dystrophin in vivo.
More description
DC77970 Pixofisiran
Pixofisiran is a siRNA in STP705. It targets to TGF‐β1. STP705 is composed of 2 siRNA oligonucleotides (Pixofisiran and Lixadesiran) that individually target TGF-β1 and COX-2 mRNA.
More description
DC77969 Pixofisiran sodium
Pixofisiran sodium is a siRNA in STP705. It targets to TGF‐β1. STP705 is composed of 2 siRNA oligonucleotides (Pixofisiran and Lixadesiran) that individually target TGF-β1 and COX-2 mRNA.
More description
DC77968 Pivicasiran
Pivicasiran, a siRNA, is a adiponutrin synthesis reducer.
More description
DC77967 Pivicasiran sodium
Pivicasiran sodium, a siRNA, is a adiponutrin synthesis reducer.
More description
DC77960 Opemalirsen
Opemalirsen is an antisense oligonucleotide targeted to apolipoprotein L1 (APOL1). It is used for the study of Kidney disorders.
More description
DC77959 Opemalirsen sodium
Opemalirsen sodium is an antisense oligonucleotide targeted to apolipoprotein L1 (APOL1). It is used for the study of Kidney disorders.
More description
DC77958 Onvuzosiran
Onvuzosiran, a siRNA, is a prekallikrein synthesis reducer.
More description
DC77957 Onvuzosiran sodium
Onvuzosiran sodium, a siRNA, is a prekallikrein synthesis reducer.
More description
DC77951 FAPI-P8PN
FAPI-P8PN is a fibroblast activation protein (FAP) inhibitor (IC50=3.6 nM). FAPI-P8PN is promising for research of FAP-overexpressing solid tumors.
More description
DC77950 OZO-H
OZO-H is a GST inhibitor. OZO-H is an OZO derivative with potent anti-cancer effects. OZO-H releases JNK1 from GST-JNK1 complex. OZO-H induces JNK1 phosphorylation and activates c-Jun in cancer cells.
More description
DC77949 OZO-Cl
OZO-Cl is an OZO derivative. OZO-Cl has anti-cancer activity. OZO-Cl significantly decreases the intracellular glutathion S-transferase Pi (GST) activity. OZO-Cl exhibits cytotoxicity to cancer cell lines, with IC50s of 150 and 120 μmol/L in Panc-1 and K562 cells respectively.
More description
DC77945 Nucresiran
Nucresiran is a siRNA that inhibits hepatic synthesis of both wild-type and variant TTR mRNA.
More description
DC77944 Nucresiran sodium
Nucresiran sodium is a siRNA that inhibits hepatic synthesis of both wild-type and variant TTR mRNA.
More description
DC77943 Nivudirsen
Nivudirsen is an antisense oligonucleotide that can promote the synthesis of functional dystrophin protein.
More description
DC77942 Nivudirsen sodium
Nivudirsen sodium is an antisense oligonucleotide that can promote the synthesis of functional dystrophin protein.
More description
DC77937 FBnG-amino-PEG3-C2-azido
FBnG-amino-PEG3-C2-azido is a tag-linker conjugate that incorporates a degradation tag FBnG and a glycol linker (Amino-PEG3-C2-Azido). FBnG-amino-PEG3-C2-azido can be used for synthesis of GPX4-AUTAC
More description
DC77936 Duazomycin sodium
Duazomycin (Duazomycin A) sodium is a glutamine antagonist. Duazomycin sodium can significantly enhance the effectiveness of 6-Mercaptopurine (6-MP) in experimental allergic encephalomyelitis (EAE) without increasing toxicity.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X